LEWIS JOEL

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$79,465.29
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of LEWIS JOEL

According to the SEC Form 4 filings, LEWIS JOEL, being in a position of

  1. President and CEO at Galectin Therapeutics Inc.,
    оver the last 12 months, has bought 1000 shares for $3,390, and sold 0 shares,
    over all time since 2018-06-25, has bought 18516 shares for $79,465, and sold 0 shares.

The largest purchase of all time was on 2019-05-31 and amounted to 12849 shares of Galectin Therapeutics Inc. for $54,994.

Biography of LEWIS JOEL

No biography is available at this moment.

2024-04-24PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
1,000
0.0016%
$3.39$3,390-19.15%
2023-02-16PurchaseGalectin Therapeutics Inc.
GALT
1,000
0.0017%
$1.52$1,520+17.33%
2019-05-31PurchaseGalectin Therapeutics Inc.
GALT
director
12,849
0.0271%
$4.28$54,994-23.33%
2019-04-05PurchaseGalectin Therapeutics Inc.
GALT
director
667
0.0013%
$4.82$3,214-24.74%
2019-02-07PurchaseGalectin Therapeutics Inc.
GALT
director
1,000
0.0022%
$4.48$4,484-13.53%
2019-01-29PurchaseGalectin Therapeutics Inc.
GALT
director
1,000
0.0021%
$4.80$4,805-21.54%
2018-06-25PurchaseGalectin Therapeutics Inc.
GALT
director
1,000
0.0026%
$7.06$7,058-31.42%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.